Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A physiological basis for the treatment of essential hypertension.

× No keyword cloud information.

17 in total

1. Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity.

Authors: J I Drayer; H J Keim; M A Weber; D B Case; J H Laragh
Journal: Am J Med Date: 1976-05-31 Impact factor: 4.965

Review 2. Vasodilator drugs in the treatment of hypertension.

Authors: J Koch-Weser
Journal: Arch Intern Med Date: 1974-06

3. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.

Authors: J H Laragh
Journal: Am J Med Date: 1973-09 Impact factor: 4.965

4. Essential hypertension: renin and aldosterone, heart attack and stroke.

Authors: H R Brunner; J H Laragh; L Baer; M A Newton; F T Goodwin; L R Krakoff; R H Bard; F R Bühler
Journal: N Engl J Med Date: 1972-03-02 Impact factor: 91.245

5. Angiotensin blockade: its clinical significance.

Authors: D H Streeten; G H Anderson; T H Dalakos
Journal: Am J Med Date: 1976-05-31 Impact factor: 4.965

6. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.

Authors: D B Case; J M Wallace; H J Keim; J E Sealey; J H Laragh
Journal: Am J Med Date: 1976-05-31 Impact factor: 4.965

A physiological basis for the treatment of essential hypertension.

1. Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity.

Review 2. Vasodilator drugs in the treatment of hypertension.

3. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.

4. Essential hypertension: renin and aldosterone, heart attack and stroke.

5. Angiotensin blockade: its clinical significance.

6. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.

7. Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.

8. Side effects of hypotensive agents evaluated by a self-administered questionnaire.

9. Reciprocal relation between renin dependency and sodium dependency in essential hypertension.

10. Renin and aldosterone suppression in the antihypertensive action of clonidine.